Diversified investment company BPH Energy (ASX: BPH) will take plenty of momentum into the new calendar year after its investee companies undertook a range of needle-moving activities during the September 2025 quarter.
BPH has investments in companies making strides in both biotechnology and the resources sector.
They include oil and gas developer Advent Energy, in which BPH has a 35.8% direct interest.
PEP11 Court Hearing
Advent’s wholly owned subsidiary Asset Energy is a participant in the PEP11 joint venture offshore New South Wales, which is awaiting the outcome of a drawn-out court hearing.
The legal matter covering the status of the PEP11 permit – originally set for hearing in mid-September – was postponed until February 2026, after issues on technical points of law were raised.
The JV believes the PEP11 permit has significant potential for a gas discovery to help meet growing energy demand on the east coast of Australia.
Cortical Dynamics Advances
Elsewhere, neurotechnology company Cortical Dynamics – in which BPH has a direct 16.4% interest – expects to achieve technical completion of its AI enhanced brain- and pain-monitoring system in coming months.
Cortical is developing the BARM 2.0 solution to support clinicians through real-time control over anesthesia, and help hospitals achieve better patient outcomes—both during and after surgery.
BPH has scheduled clinical trials in the USA and the Netherlands over coming months, after which it plans to make submissions to international regulatory authorities.
Cortical got to showcase BARM 2.0 at a number of major industry and government events during the September quarter, providing an opportunity to connect directly with those leading healthcare innovation as well as their patients.
CORDYAN AI App
Cortical also continues to progress CORDYAN, its new predictive AI App initiative.
Utilising its proprietary state of the art AI and deep learning expertise, Cortical is developing a range of medical Apps for standalone use, with BARM 2.0, or via integration into leading healthcare systems.
CORDYAN has been awarded matching grants from ARM-hub, a federal government program to accelerate AI-related technologies in areas of strategic importance, as well as Australian MedTech governmental organisation MTPConnect.
CHT Pilot Plant
Meanwhile, Clean Hydrogen Technologies (CHT) – another investment, in which BPH holds a 16.2% interest – is progressing plans to build facilities in the USA and India for the production of hydrogen fuel with minimal to zero carbon emissions, to help decarbonise sectors such as transport, steel, and energy.
Since mid-2024, CHT has been designing its production facility for Maharashtra, India, which at the end of its Stage 1 build will produce 820 tonnes of hydrogen and 2,462 tonnes of carbon composite.
The company is currently sourcing the $3.8 million it needs to build the US and Indian plants, and is confident that it can start achieving income within a few months of commencing operations.
